Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
27.79%
大市值
37.89%
中市值
34.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 132  
0%
 
100%
     10大 (16.14%)
代號 名稱 佔比% ▼ 持有日期
BHVNBiohaven Ltd1.0630/10/2026
QUITAchieve Life Sciences Inc.1.0630/09/2026
FDMT4D Molecular Therapeutics1.0530/10/2026
PVLAPalvella Therapeutics Inc1.0430/10/2026
VIRVir Biotechnology1.0230/10/2026
MAZEMaze Therapeutics Inc1.0230/10/2026
PCVXVaxcyte1.0130/10/2026
JANXJanux Therapeutics1.0030/10/2026
RXRXRecursion Pharmaceuticals0.9930/10/2026
RVMDRevolution Medicines0.9630/10/2026
RLAYRelay Therapeutics0.9630/10/2026
SLSSELLAS Life Sciences Group0.9630/10/2026
SEPNSepterna Inc0.9530/10/2026
KYMRKymera Therapeutics0.9430/09/2026
SYRESpyre Therapeutics0.9330/10/2026
IRONDisc Medicine0.9230/10/2026
MNPRMonopar Therapeutics Inc0.9130/10/2026
GENBGenerate Biomedicines, Inc.0.9130/10/2026
SMMTSummit Therapeutics0.8930/10/2026
BLTEBelite Bio0.8730/10/2026
  1   2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.